Stay updated on Psilocybin for MDD: Novel Clinical Trial
Sign up to get notified when there's something new on the Psilocybin for MDD: Novel Clinical Trial page.

Latest updates to the Psilocybin for MDD: Novel Clinical Trial page
- CheckyesterdayChange DetectedSite footer Revision updated from v3.5.4 to v3.5.5, indicating a new version of the site software.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page now displays Revision: v3.5.4, indicating a small update to the site’s build; no study information or functionality within the page is altered.SummaryDifference0.0%

- Check36 days agoChange DetectedRevision updated from v3.5.2 to v3.5.3, indicating a minor page version update. This administrative change does not alter the study details or the information presented on the page.SummaryDifference0.0%

- Check43 days agoChange DetectedResults were posted for this trial, including updated study record/result timing and linked documents. Key outcome measures and endpoints (MADRS change at Day 43 and Day 8, Sheehan Disability Scale change at Day 43, and sustained response/remission thresholds) were added/updated to reflect the reported analyses.SummaryDifference2%

- Check51 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2. This appears to be a minor version bump with no changes to study content, layout, or other user-facing information.SummaryDifference0.0%

- Check72 days agoChange DetectedRevision history updated: added v3.5.0 and removed v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Psilocybin for MDD: Novel Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin for MDD: Novel Clinical Trial page.